Literature DB >> 6195290

Mannose-sensitive and Gal-Gal binding Escherichia coli pili from recombinant strains. Chemical, functional, and serological properties.

P O'Hanley, D Lark, S Normark, S Falkow, G K Schoolnik.   

Abstract

Chromosomal genes encoding the MS and Gal-Gal binding properties have been cloned into separate recombinants and their respective pili characterized. Hapten inhibition of hemagglutination with synthetic carbohydrate receptor analogues and carbohydrate-adsorbed latex agglutination studies indicate that Gal-Gal and MS pili collectively exhibit the binding properties of the parent strain. MS pili migrated in SDS-PAGE with an Mr of 19 kdaltons and 17 kdaltons; the Mr of Gal-Gal pili was 17.5 kdaltons. The pili are chemically similar by amino acid composition and when the N-terminal cysteines are aligned, 8 of the 13 residues between positions 9 and 22 are homologous. Further, carboxy-terminal sequence homology was inferred from the carboxypeptidase digestion of a MS pili and the sequence of a carboxy-terminal tryptic peptide from Gal-Gal pili.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195290      PMCID: PMC2187145          DOI: 10.1084/jem.158.5.1713

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

Review 1.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Aspects on structure and function of pili on uropathogenic Escherichia coli.

Authors:  C Svanborg Edén; E C Gotschlich; T K Korhonen; H Leffler; G Schoolnik
Journal:  Prog Allergy       Date:  1983

4.  F7 and type 1-like fimbriae from three Escherichia coli strains isolated from urinary tract infections: protein chemical and immunological aspects.

Authors:  P Klemm; I Orskov; F Orskov
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

6.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

7.  Primary structure of human C-reactive protein.

Authors:  E B Oliveira; C Gotschlich; T Y Liu
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

8.  Prediction of antigenic determinants and secondary structures of the K88 and CFA1 fimbrial proteins from enteropathogenic Escherichia coli.

Authors:  P Klemm; L Mikkelsen
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  35 in total

1.  Cloning of fibA, encoding an immunogenic subunit of the fibril-like surface structure of Peptostreptococcus micros.

Authors:  B H Kremer; J J Bijlsma; J G Kusters; J de Graaff; T J van Steenbergen
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  The Product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis.

Authors:  Mary L Valenski; Sandra L Harris; Patricia A Spears; John R Horton; Paul E Orndorff
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

3.  Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains.

Authors:  K Denich; A Craiu; H Rugo; G Muralidhar; P O'Hanley
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections.

Authors:  D A Low; B A Braaten; G V Ling; D L Johnson; A L Ruby
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

Review 5.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

6.  Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model.

Authors:  M A Schmidt; P O'Hanley; D Lark; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters.

Authors:  B Lund; F P Lindberg; M Båga; S Normark
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

8.  Genetic organization of the afimbrial adhesin operon and nucleotide sequence from a uropathogenic Escherichia coli gene encoding an afimbrial adhesin.

Authors:  A Labigne-Roussel; M A Schmidt; W Walz; S Falkow
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

9.  Gene products specifying adhesion of uropathogenic Escherichia coli are minor components of pili.

Authors:  F Lindberg; B Lund; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Cloning and expression of an afimbrial adhesin (AFA-I) responsible for P blood group-independent, mannose-resistant hemagglutination from a pyelonephritic Escherichia coli strain.

Authors:  A F Labigne-Roussel; D Lark; G Schoolnik; S Falkow
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.